COMBAT-COVID Trial
1 ensayoEnsayos extraídos del pódcast de Rob Mac Sweeney
- 2022COMBAT-COVIDICU & Critical CareIn 80 intubated COVID-19 patients with severe endotheliopathy, iloprost did not significantly increase days alive without ventilation compared with placebo.